HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Tom Treasure Andrew Murday Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Edwards, R. Articles by Holt, D. W. Search for Related Content PubMed PubMed Citation Articles by Edwards, R. Articles by Holt, D. W.

Ann Thorac Surg 2000;69:551-555
© 2000 The Society of Thoracic Surgeons

---

Original Articles

A controlled trial of substrate-enhanced, warm reperfusion ("hot shot") versus simple reperfusion

^a Cardiothoracic Unit, St. George’s Hospital, London, England, United Kingdom
^b Analytical Unit, Department of Cardiological Sciences, St. George’s Hospital Medical School, London, England, United Kingdom

Address reprint requests to Dr Treasure, Cardiothoracic Unit, St. George’s Hospital, Blackshaw Rd, Tooting, London SW17 0QT England
e-mail: treasure{at}talfourd.u-net.com

Background. Modified reperfusion after aortic cross-clamping is claimed to reduce myocardial injury, thus improving postoperative myocardial performance.

Methods. We measured perioperative release of creatine kinase-MB and troponin-T in 40 patients undergoing valve replacement (combined with coronary grafts in 12 cases) to determine whether infusion of a modified reperfusate before cross-clamp removal reduced myocardial injury. Patients were randomly allocated to one of two groups with minimization for age, surgeon, operation, and ventricular function. The control group received unmodified reperfusion, while the study group received a normothermic reperfusate, enhanced with glutamate and aspartate, for 5 minutes before removal of the cross-clamp. Serial determinations of troponin-T, creatine kinase-MB isoforms, and total creatine kinase-MB activity were made up to 5 days postoperatively. Requirements for inotropic support and evidence of myocardial infarction were documented.

Results. Creatine kinase-MB activity, creatine kinase-MB isoforms, and troponin-T were not significantly different between the two groups. There were no differences in the incidence of postoperative myocardial infarction or in inotrope requirement.

Conclusions. Our study did not demonstrate any advantage in using modified reperfusion in this group of patients.

This article has been cited by other articles:

				X. Y. Jin and R. Pillai Invited Commentary Ann. Thorac. Surg., February 1, 2008; 85(2): 458 - 459. [Full Text] [PDF]

				C. Rergkliang, A. Chetpaophan, V. Chittithavorn, P. Vasinanukorn, and V. Chowchuvech Terminal Warm Blood Cardioplegia in Mitral Valve Replacement: Prospective Study Asian Cardiovasc Thorac Ann, April 1, 2006; 14(2): 134 - 138. [Abstract] [Full Text] [PDF]